0.1(top 100%)
impact factor
89(top 100%)
papers
127(top 50%)
citations
6(top 50%)
h-index
0.1(top 100%)
extended IF
92
all documents
130
doc citations
9(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1The status of the sensitization/kindling hypothesis of bipolar disorderCurrent Psychosis & Therapeutics Reports200412
2Caregiver burden in dementia care: Prevalence and health effectsCurrent Psychosis & Therapeutics Reports200510
3Cognitive disturbance in borderline personality disorder: Phenomenologic, social cognitive, and neurocognitive findingsCurrent Psychosis & Therapeutics Reports20068
4Dissociative identity disorderCurrent Psychosis & Therapeutics Reports20068
5Optimizing pharmacotherapy of schizophrenia: Tools for the psychiatristCurrent Psychosis & Therapeutics Reports20068
6Cholinergic mechanisms in schizophrenia: Current conceptsCurrent Psychosis & Therapeutics Reports20068
7Evolutionary epidemiology of endophenotypes in the bipolar spectrum: Evolved neuropsychologic mechanisms of social rankCurrent Psychosis & Therapeutics Reports20066
8Bipolar disorder in youth: An updateCurrent Psychosis & Therapeutics Reports20035
9Too much or too little pain: The dichotomy of pain sensitivity in psychotic versus other psychiatric disordersCurrent Psychosis & Therapeutics Reports20065
10Attention deficits in the development of schizophrenia: Recent evidence from genetic high-risk and prodromal studiesCurrent Psychosis & Therapeutics Reports20054
11Neurocognition in bipolar disorder: A review of the current researchCurrent Psychosis & Therapeutics Reports20043
12The neuropsychology of mood disordersCurrent Psychosis & Therapeutics Reports20053
13Psychotic symptoms in the elderlyCurrent Psychosis & Therapeutics Reports20053
14Best practice pharmacologic treatment of schizophrenia: Applying principles of evidence-based medicineCurrent Psychosis & Therapeutics Reports20053
15Glutamatergic mechanisms in schizophrenia: Current conceptsCurrent Psychosis & Therapeutics Reports20063
16Evidence-based strategies for achieving treatment goals in bipolar disorder: A review and synthesis of contemporary treatment guidelinesCurrent Psychosis & Therapeutics Reports20032
17Treating schizophrenia earlier in life and the potential for preventionCurrent Psychosis & Therapeutics Reports20032
18Post-traumatic stress disorder: Differential diagnosis and managementCurrent Psychosis & Therapeutics Reports20042
19Precursors of schizophreniaCurrent Psychosis & Therapeutics Reports20042
20Side effects of atypical antipsychotics in the geriatric populationCurrent Psychosis & Therapeutics Reports20052
21Emerging novel treatments for severe mood disorders involving cellular plasticity cascadesCurrent Psychosis & Therapeutics Reports20062
22Emerging roles of new antipsychotics in bipolar disordersCurrent Psychosis & Therapeutics Reports20031
23Update on the search for genes for bipolar disorderCurrent Psychosis & Therapeutics Reports20031
24Current concepts in rapid cycling bipolar disorderCurrent Psychosis & Therapeutics Reports20031
25Efficacy of second-generation antipsychotics in the treatment of schizophreniaCurrent Psychosis & Therapeutics Reports20031
26Emerging insights on the neuroanatomy of schizophreniaCurrent Psychosis & Therapeutics Reports20031
27Schizophrenia: Causes, course, and neurodevelopmentCurrent Psychosis & Therapeutics Reports20031
28Psychosocial therapies in bipolar disorderCurrent Psychosis & Therapeutics Reports20041
29Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: Evidence, limitations, and implicationsCurrent Psychosis & Therapeutics Reports20041
30Stress, social rhythms, and behavioral activation: Psychosocial factors and the bipolar illness courseCurrent Psychosis & Therapeutics Reports20041
31Response to lithium treatment in bipolar disorder as a pharmacogenetic phenotypeCurrent Psychosis & Therapeutics Reports20041
32Conduct disorder and other disruptive behaviors: Pediatric psychopharmacologyCurrent Psychosis & Therapeutics Reports20041
33Safety profiles of atypical antipsychotics in the elderlyCurrent Psychosis & Therapeutics Reports20041
34Vascular depression: Recent advancesCurrent Psychosis & Therapeutics Reports20041
35Anticholinergic delirium: Assessing the role of anticholinergic burden in the elderlyCurrent Psychosis & Therapeutics Reports20041
36Treating the cognitive deficits of schizophreniaCurrent Psychosis & Therapeutics Reports20041
37Endocrine disorders in schizophrenia: Relationship to antipsychotic therapyCurrent Psychosis & Therapeutics Reports20041
38Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disordersCurrent Psychosis & Therapeutics Reports20051
39Polypharmacy in schizophrenia: Science, art, and fictionCurrent Psychosis & Therapeutics Reports20051
40Stimulating development of new drugs to improve cognition in schizophreniaCurrent Psychosis & Therapeutics Reports20051
41Cognitive impairment in schizophrenia spectrum personalityCurrent Psychosis & Therapeutics Reports20051
42Amphetamine, psychosis, and cognition in the schizophrenia spectrumCurrent Psychosis & Therapeutics Reports20051
43Acute confusional states in the general elderly population: An overview of deliriumCurrent Psychosis & Therapeutics Reports20061
44Treatment refractory depression in the elderly: A possible role for repetitive transcranial magnetic stimulationCurrent Psychosis & Therapeutics Reports20061
45Delusional disorders in the elderlyCurrent Psychosis & Therapeutics Reports20061
46Serum anticholinergic radioreceptor assay: A selective review of the 25-year history of a simple ideaCurrent Psychosis & Therapeutics Reports20061
47Body dysmorphic disorder: Delusions of physical appearanceCurrent Psychosis & Therapeutics Reports20061
48Pharmacologic treatment of schizophrenia: Current status and future trendsCurrent Psychosis & Therapeutics Reports20061
49New developments in the bipolar spectrum conceptualizationCurrent Psychosis & Therapeutics Reports20030
50Safety and tolerability: How do second-generation atypical antipsychotics compare?Current Psychosis & Therapeutics Reports20030